UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM N-CSRS
CERTIFIED SHAREHOLDER REPORT OF
REGISTERED MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number: 811-07507
Deutsche DWS Investments VIT Funds
(Exact Name of Registrant as Specified in Charter)
875 Third Avenue
New York, NY 10022-6225
(Address of Principal Executive Offices) (Zip Code)
Registrant’s Telephone Number, including Area Code: (212) 454-4500
Diane Kenneally
100 Summer Street
Boston, MA 02110
(Name and Address of Agent for Service)
Date of fiscal year end: | 12/31 |
| |
Date of reporting period: | 6/30/2024 |
ITEM 1. | REPORT TO STOCKHOLDERS |
| |
| (a) |
| |
Semi-Annual Shareholder Report—June 30, 2024
This semi-annual shareholder report contains important information about DWS Small Cap Index VIP ("the Fund") for the period January 1, 2024 to June 30, 2024. You can find additional information about the Fund on the Fund's website at dws.com/vipreports. You can also request this information by contacting us at (800) 728-3337.
What were the Fund costs for the last six months?
(Based on a hypothetical $10,000 investment)
| Cost of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
---|
Class A | $19 | 0.37% |
Gross expense ratio as of the latest prospectus: 0.42%. See prospectus for any contractual or voluntary waivers; without a waiver, costs would have been higher. Fund costs do not reflect any fees or sales charges imposed by a variable contract for which the Fund is an investment option.
Net Assets ($) | 391,985,600 |
Number of Portfolio Holdings | 1,994 |
Portfolio Turnover Rate (%) | 14 |
Total Net Advisory Fees Paid ($) | 448,609 |
What did the Fund invest in?
Holdings | 3.4% of Net Assets |
---|
Insmed, Inc. | 0.4% |
FTAI Aviation Ltd. | 0.4% |
Abercrombie & Fitch Co. | 0.4% |
Fabrinet | 0.4% |
Sprouts Farmers Market, Inc. | 0.3% |
Vaxcyte, Inc. | 0.3% |
Applied Industrial Technologies, Inc. | 0.3% |
Fluor Corp. | 0.3% |
HealthEquity, Inc. | 0.3% |
SPS Commerce, Inc. | 0.3% |
Holdings-based data is subject to change.
Asset Type | % of Net Assets |
Common Stocks | 99% |
Cash Equivalents | 1% |
Government & Agency Obligations | 0% |
Rights | 0% |
Warrants | 0% |
Other Investments | 0% |
Other Assets and Liabilities, Net | 0% |
Total | 100% |
Sector | % of Net Assets |
Industrials | 17% |
Health Care | 17% |
Financials | 17% |
Information Technology | 13% |
Consumer Discretionary | 10% |
Energy | 7% |
Real Estate | 6% |
Materials | 4% |
Consumer Staples | 3% |
Utilities | 3% |
Communication Services | 2% |
Total | 99% |
If you wish to view additional information about the Fund, including, but not limited to, its prospectus, quarterly holdings, Board fee evaluation reports, and financial statements and other information, please visit dws.com/vipreports. For information about the Fund's proxy voting policies and procedures and how the Fund voted proxies related to its portfolio securities, please visit dws.com/en-us/resources/proxy-voting. This additional information is also available free of charge by contacting us at (800) 728-3337.
Stocks may decline in value. Various factors, including costs, cash flows and security selection, may cause the Fund’s performance to differ from that of the index. Smaller company stocks tend to be more volatile than medium-sized or large company stocks. The Fund may lend securities to approved institutions. Investing in derivatives entails special risks relating to liquidity, leverage and credit that may reduce returns and/or increase volatility. Please read the prospectus for details.
This report must be preceded or accompanied by a prospectus. We advise you to consider the Fund's objectives, risks, charges, and expenses carefully before investing. The prospectus contains this and other important information about the Fund, which can be requested by calling (800) 728-3337, contacting your financial representative, or visit dws.com/vipreports to view or download a prospectus. Please read the prospectus carefully before you invest.
The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc., which offers investment products, or DWS Investment Management Americas, Inc. and RREEF America L.L.C., which offer advisory services.
©2024 DWS Group GmbH&Co. KGaA. All rights reserved
vit-scif-TSRS-A
R-101781-1 (8/24)
Semi-Annual Shareholder Report—June 30, 2024
This semi-annual shareholder report contains important information about DWS Small Cap Index VIP ("the Fund") for the period January 1, 2024 to June 30, 2024. You can find additional information about the Fund on the Fund's website at dws.com/vipreports. You can also request this information by contacting us at (800) 728-3337.
What were the Fund costs for the last six months?
(Based on a hypothetical $10,000 investment)
| Cost of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
---|
Class B | $34 | 0.67% |
Gross expense ratio as of the latest prospectus: 0.73%. See prospectus for any contractual or voluntary waivers; without a waiver, costs would have been higher. Fund costs do not reflect any fees or sales charges imposed by a variable contract for which the Fund is an investment option.
Net Assets ($) | 391,985,600 |
Number of Portfolio Holdings | 1,994 |
Portfolio Turnover Rate (%) | 14 |
Total Net Advisory Fees Paid ($) | 448,609 |
What did the Fund invest in?
Holdings | 3.4% of Net Assets |
---|
Insmed, Inc. | 0.4% |
FTAI Aviation Ltd. | 0.4% |
Abercrombie & Fitch Co. | 0.4% |
Fabrinet | 0.4% |
Sprouts Farmers Market, Inc. | 0.3% |
Vaxcyte, Inc. | 0.3% |
Applied Industrial Technologies, Inc. | 0.3% |
Fluor Corp. | 0.3% |
HealthEquity, Inc. | 0.3% |
SPS Commerce, Inc. | 0.3% |
Holdings-based data is subject to change.
Asset Type | % of Net Assets |
Common Stocks | 99% |
Cash Equivalents | 1% |
Government & Agency Obligations | 0% |
Rights | 0% |
Warrants | 0% |
Other Investments | 0% |
Other Assets and Liabilities, Net | 0% |
Total | 100% |
Sector | % of Net Assets |
Industrials | 17% |
Health Care | 17% |
Financials | 17% |
Information Technology | 13% |
Consumer Discretionary | 10% |
Energy | 7% |
Real Estate | 6% |
Materials | 4% |
Consumer Staples | 3% |
Utilities | 3% |
Communication Services | 2% |
Total | 99% |
If you wish to view additional information about the Fund, including, but not limited to, its prospectus, quarterly holdings, Board fee evaluation reports, and financial statements and other information, please visit dws.com/vipreports. For information about the Fund's proxy voting policies and procedures and how the Fund voted proxies related to its portfolio securities, please visit dws.com/en-us/resources/proxy-voting. This additional information is also available free of charge by contacting us at (800) 728-3337.
Stocks may decline in value. Various factors, including costs, cash flows and security selection, may cause the Fund’s performance to differ from that of the index. Smaller company stocks tend to be more volatile than medium-sized or large company stocks. The Fund may lend securities to approved institutions. Investing in derivatives entails special risks relating to liquidity, leverage and credit that may reduce returns and/or increase volatility. Please read the prospectus for details.
This report must be preceded or accompanied by a prospectus. We advise you to consider the Fund's objectives, risks, charges, and expenses carefully before investing. The prospectus contains this and other important information about the Fund, which can be requested by calling (800) 728-3337, contacting your financial representative, or visit dws.com/vipreports to view or download a prospectus. Please read the prospectus carefully before you invest.
The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc., which offers investment products, or DWS Investment Management Americas, Inc. and RREEF America L.L.C., which offer advisory services.
©2024 DWS Group GmbH&Co. KGaA. All rights reserved
vit-scif-TSRS-B
R-101781-1 (8/24)
| |
| (b) Not applicable |
| |
Item 2. | Code of Ethics. |
| |
| Not applicable |
| |
Item 3. | Audit Committee Financial Expert. |
| |
| Not applicable |
| |
Item 4. | Principal Accountant Fees and Services. |
| |
| Not applicable |
| |
Item 5. | Audit Committee of Listed Registrants. |
| |
| Not applicable |
| |
Item 6. | Investments. |
| |
| Not applicable |
| |
Item 7. | Financial Statements and Financial Highlights for Open-End Management Investment Companies. |
| |
June 30, 2024
Semiannual Financial Statements and Other Information
Deutsche DWS Investments VIT Funds
The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc., which offers investment products, or DWS Investment Management Americas, Inc. and RREEF America L.L.C., which offer advisory services.DWS Distributors, Inc., 222 South Riverside Plaza, Chicago, IL 60606, (800) 621-1148
Investment Portfolioas of June 30, 2024 (Unaudited)
| | |
| |
Communication Services 2.4% | |
Diversified Telecommunication Services 0.4% | |
| | | |
AST SpaceMobile, Inc.* (a) | | | |
| | | |
| | | |
Cogent Communications Holdings, Inc. | | | |
Consolidated Communications Holdings, Inc.* | | | |
| | | |
| | | |
Liberty Latin America Ltd. "A"* | | | |
Liberty Latin America Ltd. "C"* | | | |
Lumen Technologies, Inc.* | | | |
Shenandoah Telecommunications Co. | | | |
| | | |
| |
Amc Entertainment Holdings, Inc. "A"* | | | |
Atlanta Braves Holdings, Inc. "A"* | | | |
Atlanta Braves Holdings, Inc. "C"* | | | |
| | | |
| | | |
Golden Matrix Group, Inc.* | | | |
| | | |
Lions Gate Entertainment Corp. "A"* | | | |
Lions Gate Entertainment Corp. "B"* | | | |
| | | |
Madison Square Garden Entertainment Corp.* | | | |
| | | |
| | | |
| | | |
Sphere Entertainment Co.* | | | |
| | | |
| | | |
Interactive Media & Services 0.6% | |
| | | |
| | | |
| | | |
| | | |
| | | |
Getty Images Holdings, Inc.* | | | |
| | | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
Advantage Solutions, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
Clear Channel Outdoor Holdings, Inc.* | | | |
| | | |
| | | |
Entravision Communications Corp. "A" | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Integral Ad Science Holding Corp.* | | | |
John Wiley & Sons, Inc. "A" | | | |
| | | |
National CineMedia, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
The E.W. Scripps Co. "A"* | | | |
| | | |
Townsquare Media, Inc. "A" | | | |
| | | |
| | | |
Wireless Telecommunication Services 0.1% | |
| | | |
| | | |
Telephone & Data Systems, Inc. | | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
Consumer Discretionary 9.9% | |
Automobile Components 1.3% | |
| | | |
American Axle & Manufacturing Holdings, Inc.* | | | |
Cooper-Standard Holdings, Inc.* | | | |
| | | |
| | | |
Fox Factory Holding Corp.* | | | |
| | | |
Goodyear Tire & Rubber Co.* | | | |
| | | |
| | | |
Luminar Technologies, Inc.* (a) | | | |
Modine Manufacturing Co.* | | | |
| | | |
| | | |
| | | |
Standard Motor Products, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| | | |
Winnebago Industries, Inc. | | | |
| | | |
| |
| | | |
| | | |
Savers Value Village, Inc.* | | | |
| | | |
| |
A-Mark Precious Metals, Inc. | | | |
GigaCloud Technology, Inc. "A"* | | | |
| | | |
| | | |
Diversified Consumer Services 0.9% | |
Adtalem Global Education, Inc.* | | | |
American Public Education, Inc.* | | | |
| | | |
| | | |
| | | |
European Wax Center, Inc. "A"* | | | |
| | | |
| | | |
| | |
| | | |
Lincoln Educational Services Corp.* | | | |
| | | |
| | | |
OneSpaWorld Holdings Ltd.* | | | |
| | | |
Strategic Education, Inc. | | | |
| | | |
| | | |
Universal Technical Institute, Inc.* | | | |
| | | |
Hotels, Restaurants & Leisure 1.8% | |
Accel Entertainment, Inc.* | | | |
| | | |
Biglari Holdings, Inc. "B"* | | | |
| | | |
| | | |
Brinker International, Inc.* | | | |
| | | |
Cracker Barrel Old Country Store, Inc. | | | |
Dave & Buster's Entertainment, Inc.* | | | |
| | | |
| | | |
| | | |
El Pollo Loco Holdings, Inc.* | | | |
Empire Resorts, Inc.* (b) | | | |
| | | |
First Watch Restaurant Group, Inc.* (a) | | | |
Full House Resorts, Inc.* | | | |
Global Business Travel Group I* | | | |
Golden Entertainment, Inc. | | | |
Hilton Grand Vacations, Inc.* | | | |
Inspired Entertainment, Inc.* | | | |
International Game Technology PLC | | | |
| | | |
| | | |
Kura Sushi USA, Inc. "A"* | | | |
Life Time Group Holdings, Inc.* | | | |
Lindblad Expeditions Holdings, Inc.* | | | |
Monarch Casino & Resort, Inc. | | | |
| | | |
| | | |
Papa John's International, Inc. | | | |
| | | |
| | | |
| | | |
RCI Hospitality Holdings, Inc. | | | |
The accompanying notes are an integral part of the financial statements.
| | |
Red Rock Resorts, Inc. "A" | | | |
Rush Street Interactive, Inc.* | | | |
| | | |
| | | |
Six Flags Entertainment Corp. | | | |
| | | |
| | | |
Target Hospitality Corp.* | | | |
The Cheesecake Factory, Inc. | | | |
The ONE Group Hospitality, Inc.* | | | |
United Parks & Resorts, Inc.* | | | |
| | | |
Xponential Fitness, Inc. "A"* | | | |
| | | |
| |
Beazer Homes U.S.A., Inc.* | | | |
| | | |
Century Communities, Inc. | | | |
| | | |
Dream Finders Homes, Inc. "A"* | | | |
Ethan Allen Interiors, Inc. | | | |
Flexsteel Industries, Inc. | | | |
| | | |
Green Brick Partners, Inc.* | | | |
Hamilton Beach Brands Holding Co. "A" | | | |
| | | |
| | | |
Hovnanian Enterprises, Inc. "A"* | | | |
Installed Building Products, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Taylor Morrison Home Corp.* | | | |
| | | |
| | | |
United Homes Group, Inc.* (a) | | | |
| | | |
Worthington Enterprises, Inc. | | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Johnson Outdoors, Inc. "A" | | | |
| | | |
| | | |
| | | |
MasterCraft Boat Holdings, Inc.* | | | |
Peloton Interactive, Inc. "A"* | | | |
Smith & Wesson Brands, Inc. | | | |
| | | |
| | | |
Topgolf Callaway Brands Corp.* | | | |
| | | |
| | | |
| |
1-800-Flowers.com, Inc. "A"* | | | |
| | | |
Abercrombie & Fitch Co. "A"* | | | |
Academy Sports & Outdoors, Inc. | | | |
American Eagle Outfitters, Inc. | | | |
America's Car-Mart, Inc.* | | | |
| | | |
| | | |
Asbury Automotive Group, Inc.* | | | |
| | | |
| | | |
Boot Barn Holdings, Inc.* | | | |
Build-a-bear Workshop, Inc. | | | |
| | | |
Camping World Holdings, Inc. "A" | | | |
| | | |
Designer Brands, Inc. "A" | | | |
Destination XL Group, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Haverty Furniture Companies, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
National Vision Holdings, Inc.* | | | |
| | | |
OneWater Marine, Inc. "A"* | | | |
Petco Health & Wellness Co., Inc.* | | | |
| | | |
| | | |
| | | |
Sally Beauty Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
Sonic Automotive, Inc. "A" | | | |
| | | |
| | | |
| | | |
Tile Shop Holdings, Inc.* | | | |
| | | |
Torrid Holdings, Inc.* (a) | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Textiles, Apparel & Luxury Goods 0.6% | |
| | | |
G-III Apparel Group Ltd.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Superior Group of Companies, Inc. | | | |
| | | |
Wolverine World Wide, Inc. | | | |
| | | |
| |
| |
| | | |
| | | |
| | | |
The Duckhorn Portfolio, Inc.* | | | |
| | | |
| | | |
Consumer Staples Distribution & Retail 0.7% | |
| | | |
| | | |
Natural Grocers by Vitamin Cottage, Inc. | | | |
| | |
| | | |
| | | |
Sprouts Farmers Market, Inc.* | | | |
| | | |
The Chefs' Warehouse, Inc.* | | | |
United Natural Foods, Inc.* | | | |
Village Super Market, Inc. "A" | | | |
| | | |
| | | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Fresh Del Monte Produce, Inc. | | | |
Hain Celestial Group, Inc.* | | | |
| | | |
John B. Sanfilippo & Son, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Whole Earth Brands, Inc.* | | | |
| | | |
| | | |
| |
Central Garden & Pet Co.* | | | |
Central Garden & Pet Co. "A"* | | | |
| | | |
| | | |
| | | |
| | | |
Personal Care Products 0.3% | |
Edgewell Personal Care Co. | | | |
| | | |
| | | |
| | | |
| | | |
Nature's Sunshine Products, Inc.* | | | |
The accompanying notes are an integral part of the financial statements.
| | |
Nu Skin Enterprises, Inc. "A" | | | |
| | | |
| | | |
USANA Health Sciences, Inc.* | | | |
| | | |
| | | |
| | | |
| |
| | | |
Turning Point Brands, Inc. | | | |
| | | |
| | | |
| | | |
| |
Energy Equipment & Services 2.7% | |
| | | |
Atlas Energy Solutions, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Diamond Offshore Drilling, Inc.* | | | |
| | | |
Drilling Tools International Corp.* | | | |
| | | |
| | | |
Forum Energy Technologies, Inc.* | | | |
Geospace Technologies Corp.* | | | |
Helix Energy Solutions Group, Inc.* | | | |
| | | |
Kodiak Gas Services, Inc. | | | |
| | | |
Mammoth Energy Services, Inc.* | | | |
| | | |
Natural Gas Services Group, Inc.* | | | |
| | | |
| | | |
Oceaneering International, Inc.* | | | |
Oil States International, Inc.* | | | |
Patterson-UTI Energy, Inc. | | | |
ProFrac Holding Corp. "A"* (a) | | | |
| | | |
Ranger Energy Services, Inc. | | | |
| | | |
SEACOR Marine Holdings, Inc.* | | | |
| | |
| | | |
Select Water Solutions, Inc. | | | |
Solaris Oilfield Infrastructure, Inc. "A" | | | |
TETRA Technologies, Inc.* | | | |
| | | |
| | | |
U.S. Silica Holdings, Inc.* | | | |
| | | |
| | | |
Oil, Gas & Consumable Fuels 3.8% | |
| | | |
| | | |
| | | |
| | | |
California Resources Corp. | | | |
Centrus Energy Corp. "A"* | | | |
Clean Energy Fuels Corp.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Delek U.S. Holdings, Inc. | | | |
| | | |
Diversified Energy Co. PLC REG S | | | |
| | | |
| | | |
| | | |
| | | |
Equitrans Midstream Corp. | | | |
Evolution Petroleum Corp. | | | |
Excelerate Energy, Inc. "A" | | | |
| | | |
| | | |
| | | |
Granite Ridge Resources, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
International Seaways, Inc. | | | |
| | | |
| | | |
Magnolia Oil & Gas Corp. "A" | | | |
| | | |
NACCO Industries, Inc. "A" | | | |
| | | |
Nordic American Tankers Ltd. | | | |
Northern Oil and Gas, Inc. | | | |
Overseas Shipholding Group, Inc. "A" | | | |
Par Pacific Holdings, Inc.* | | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
PrimeEnergy Resources Corp.* | | | |
REX American Resources Corp.* | | | |
Riley Exploration Permian, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
SilverBow Resources, Inc.* | | | |
Sitio Royalties Corp. "A" | | | |
| | | |
| | | |
| | | |
| | | |
Uranium Energy Corp.* (a) | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| |
| | | |
| | | |
Amalgamated Financial Corp. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Atlantic Union Bankshares Corp. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Bank of NT Butterfield & Son Ltd. | | | |
| | | |
| | | |
Bankwell Financial Group, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Berkshire Hills Bancorp., Inc. | | | |
| | | |
| | |
Bridgewater Bancshares, Inc.* | | | |
| | | |
Burke & Herbert Financial Services Corp. | | | |
Business First Bancshares, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Capital City Bank Group, Inc. | | | |
Capitol Federal Financial, Inc. | | | |
| | | |
| | | |
Central Pacific Financial Corp. | | | |
| | | |
ChoiceOne Financial Services, Inc. | | | |
Citizens & Northern Corp. | | | |
Citizens Financial Services, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Codorus Valley Bancorp., Inc. | | | |
| | | |
Columbia Financial, Inc.* | | | |
Community Financial System, Inc. | | | |
Community Trust Bancorp., Inc. | | | |
Community West Bancshares | | | |
ConnectOne Bancorp., Inc. | | | |
CrossFirst Bankshares, Inc.* | | | |
Customers Bancorp., Inc.* | | | |
| | | |
Dime Community Bancshares, Inc. | | | |
| | | |
| | | |
Enterprise Bancorp., Inc. | | | |
Enterprise Financial Services Corp. | | | |
Equity Bancshares, Inc. "A" | | | |
Esquire Financial Holdings, Inc. | | | |
| | | |
Farmers & Merchants Bancorp., Inc. | | | |
Farmers National Banc Corp. | | | |
| | | |
Fidelity D&D Bancorp, Inc. | | | |
Financial Institutions, Inc. | | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
First BanCorp. - North Carolina | | | |
| | | |
| | | |
| | | |
| | | |
First Business Financial Services, Inc. | | | |
First Commonwealth Financial Corp. | | | |
First Community Bancshares, Inc. | | | |
| | | |
First Financial Bankshares, Inc. | | | |
| | | |
First Financial Northwest, Inc. | | | |
| | | |
| | | |
First Interstate BancSystem, Inc. "A" | | | |
| | | |
First Mid Bancshares, Inc. | | | |
First of Long Island Corp. | | | |
First Western Financial, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
German American Bancorp., Inc. | | | |
| | | |
Great Southern Bancorp., Inc. | | | |
Greene County Bancorp., Inc. | | | |
Guaranty Bancshares, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Heartland Financial U.S.A., Inc. | | | |
| | | |
| | | |
| | | |
Hingham Institution For Savings (a) | | | |
| | | |
| | | |
| | | |
HomeTrust Bancshares, Inc. | | | |
| | | |
| | | |
| | | |
Independent Bank Group, Inc. | | | |
| | |
International Bancshares Corp. | | | |
| | | |
John Marshall Bancorp, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Live Oak Bancshares, Inc. | | | |
| | | |
| | | |
Metrocity Bankshares, Inc. | | | |
Metropolitan Bank Holding Corp.* | | | |
| | | |
| | | |
Midland States Bancorp., Inc. | | | |
MidWestOne Financial Group, Inc. | | | |
| | | |
National Bank Holdings Corp. "A" | | | |
National Bankshares, Inc. | | | |
| | | |
| | | |
New York Community Bancorp, Inc. | | | |
| | | |
| | | |
Northeast Community Bancorp, Inc. | | | |
Northfield Bancorp., Inc. | | | |
| | | |
Northwest Bancshares, Inc. | | | |
| | | |
| | | |
OceanFirst Financial Corp. | | | |
| | | |
| | | |
Old Second Bancorp., Inc. | | | |
Orange County Bancorp, Inc. | | | |
| | | |
Orrstown Financial Services, Inc. | | | |
Pacific Premier Bancorp., Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Peapack-Gladstone Financial Corp. | | | |
Peoples Bancorp of North Carolina, Inc. | | | |
| | | |
Peoples Financial Services Corp. | | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
Ponce Financial Group, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Provident Financial Services, Inc. | | | |
| | | |
| | | |
Red River Bancshares, Inc. | | | |
| | | |
Republic Bancorp., Inc. "A" | | | |
| | | |
Sandy Spring Bancorp., Inc. | | | |
Seacoast Banking Corp. of Florida | | | |
ServisFirst Bancshares, Inc. | | | |
| | | |
| | | |
Simmons First National Corp. "A" | | | |
| | | |
South Plains Financial, Inc. | | | |
Southern California Bancorp.* | | | |
Southern First Bancshares, Inc.* | | | |
Southern Missouri Bancorp., Inc. | | | |
Southern States Bancshares, Inc. | | | |
Southside Bancshares, Inc. | | | |
| | | |
| | | |
| | | |
Stock Yards Bancorp., Inc. | | | |
Texas Capital Bancshares, Inc.* | | | |
| | | |
Third Coast Bancshares, Inc.* | | | |
Timberland Bancorp., Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
United Community Banks, Inc. | | | |
| | | |
| | | |
USCB Financial Holdings, Inc. | | | |
| | | |
| | | |
| | |
Virginia National Bankshares Corp. | | | |
| | | |
Washington Trust Bancorp., Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
Artisan Partners Asset Management, Inc. "A" | | | |
AssetMark Financial Holdings, Inc.* | | | |
B. Riley Financial, Inc. (a) | | | |
| | | |
Brightsphere Investment Group, Inc. | | | |
| | | |
Diamond Hill Investment Group, Inc. | | | |
Donnelley Financial Solutions, Inc.* | | | |
Forge Global Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Patria Investments Ltd. "A" | | | |
Perella Weinberg Partners | | | |
| | | |
| | | |
Silvercrest Asset Management Group, Inc. "A" | | | |
StepStone Group, Inc. "A" | | | |
| | | |
| | | |
Victory Capital Holdings, Inc. "A" | | | |
Virtus Investment Partners, Inc. | | | |
| | | |
| | | |
| |
Atlanticus Holdings Corp.* | | | |
Bread Financial Holdings, Inc. | | | |
Consumer Portfolio Services, Inc.* | | | |
Encore Capital Group, Inc.* | | | |
Enova International, Inc.* | | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
| | | |
Medallion Financial Corp. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Regional Management Corp. | | | |
| | | |
| | | |
| | | |
| |
| | | |
| | | |
AvidXchange Holdings, Inc.* | | | |
Banco Latinoamericano de Comercio Exterior SA | | | |
| | | |
| | | |
| | | |
Cass Information Systems, Inc. | | | |
Compass Diversified Holdings | | | |
| | | |
| | | |
| | | |
Federal Agricultural Mortgage Corp. "C" | | | |
| | | |
Hannon Armstrong Sustainable Infrastructure Capital, Inc. (a) | | | |
| | | |
International Money Express, Inc.* | | | |
Jackson Financial, Inc. "A" | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Pagseguro Digital Ltd. "A"* | | | |
| | | |
| | | |
| | | |
PennyMac Financial Services, Inc. | | | |
Priority Technology Holdings, Inc.* | | | |
| | | |
| | | |
| | |
| | | |
| | | |
| | | |
| | | |
Velocity Financial, Inc.* | | | |
| | | |
Waterstone Financial, Inc. | | | |
| | | |
| |
Ambac Financial Group, Inc.* | | | |
American Coastal Insurance Corp. "C"* | | | |
| | | |
Baldwin Insurance Group, Inc.* | | | |
CNO Financial Group, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
F&G Annuities & Life, Inc. | | | |
Fidelis Insurance Holdings Ltd. | | | |
Genworth Financial, Inc. "A"* | | | |
| | | |
Goosehead Insurance, Inc. "A"* | | | |
Greenlight Capital Re Ltd. "A"* | | | |
Hamilton Insurance Group Ltd. "B"* | | | |
| | | |
Heritage Insurance Holdings, Inc.* | | | |
| | | |
Horace Mann Educators Corp. | | | |
| | | |
James River Group Holdings Ltd. | | | |
Kingsway Financial Services, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
National Western Life Group, Inc. "A" | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Safety Insurance Group, Inc. | | | |
Selective Insurance Group, Inc. | | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
Skyward Specialty Insurance Group, Inc.* | | | |
Stewart Information Services Corp. | | | |
| | | |
| | | |
| | | |
Universal Insurance Holdings, Inc. | | | |
| | | |
Mortgage Real Estate Investment Trusts (REITs) 1.0% | |
| | | |
AG Mortgage Investment Trust, Inc. | | | |
Angel Oak Mortgage REIT, Inc. | | | |
Apollo Commercial Real Estate Finance, Inc. | | | |
Arbor Realty Trust, Inc. (a) | | | |
Ares Commercial Real Estate Corp. | | | |
ARMOUR Residential REIT, Inc. (a) | | | |
Blackstone Mortgage Trust, Inc. "A" (a) | | | |
BrightSpire Capital, Inc. | | | |
Chicago Atlantic Real Estate Finance, Inc. | | | |
| | | |
Claros Mortgage Trust, Inc. | | | |
| | | |
Ellington Financial, Inc. | | | |
Franklin BSP Realty Trust, Inc. | | | |
Granite Point Mortgage Trust, Inc. | | | |
Invesco Mortgage Capital, Inc. | | | |
KKR Real Estate Finance Trust, Inc. | | | |
| | | |
| | | |
New York Mortgage Trust, Inc. | | | |
Nexpoint Real Estate Finance, Inc. | | | |
Orchid Island Capital, Inc. (a) | | | |
PennyMac Mortgage Investment Trust | | | |
| | | |
| | | |
| | | |
TPG RE Finance Trust, Inc. | | | |
Two Harbors Investment Corp. | | | |
| | | |
| | |
| |
| |
| | | |
4D Molecular Therapeutics, Inc.* | | | |
| | | |
| | | |
ACADIA Pharmaceuticals, Inc.* | | | |
| | | |
Achieve Life Sciences, Inc.* | | | |
Acrivon Therapeutics, Inc.* | | | |
Actinium Pharmaceuticals, Inc.* | | | |
Acumen Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
Adverum Biotechnologies, Inc.* | | | |
Aerovate Therapeutics, Inc.* | | | |
| | | |
Agios Pharmaceuticals, Inc.* | | | |
Akebia Therapeutics, Inc.* | | | |
Akero Therapeutics, Inc.* | | | |
Aldeyra Therapeutics, Inc.* | | | |
| | | |
| | | |
Allogene Therapeutics, Inc.* | | | |
| | | |
ALX Oncology Holdings, Inc.* | | | |
Amicus Therapeutics, Inc.* | | | |
| | | |
Anavex Life Sciences Corp.* (a) | | | |
Anika Therapeutics, Inc.* | | | |
| | | |
Apogee Therapeutics, Inc.* | | | |
Applied Therapeutics, Inc.* | | | |
| | | |
| | | |
Arcturus Therapeutics Holdings, Inc.* | | | |
| | | |
Arcutis Biotherapeutics, Inc.* | | | |
| | | |
ArriVent Biopharma, Inc.* (a) | | | |
Arrowhead Pharmaceuticals, Inc.* | | | |
ARS Pharmaceuticals, Inc.* | | | |
Astria Therapeutics, Inc.* | | | |
Atossa Therapeutics, Inc.* | | | |
| | | |
Aurinia Pharmaceuticals, Inc.* | | | |
| | | |
Avidity Biosciences, Inc.* | | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
| | | |
BioCryst Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
Black Diamond Therapeutics, Inc.* | | | |
| | | |
Blueprint Medicines Corp.* | | | |
| | | |
| | | |
| | | |
| | | |
Candel Therapeutics, Inc.* | | | |
Capricor Therapeutics, Inc.* | | | |
| | | |
| | | |
Cargo Therapeutics, Inc.* | | | |
Caribou Biosciences, Inc.* | | | |
Cartesian Therapeutics, Inc.* | | | |
Catalyst Pharmaceuticals, Inc.* | | | |
| | | |
Celldex Therapeutics, Inc.* | | | |
Century Therapeutics, Inc.* | | | |
| | | |
| | | |
| | | |
Cogent Biosciences, Inc.* | | | |
Coherus Biosciences, Inc.* | | | |
Compass Therapeutics, Inc.* | | | |
Corbus Pharmaceuticals Holdings, Inc.* | | | |
Crinetics Pharmaceuticals, Inc.* | | | |
Cullinan Therapeutics, Inc.* | | | |
| | | |
Day One Biopharmaceuticals, Inc.* | | | |
Denali Therapeutics, Inc.* | | | |
Design Therapeutics, Inc.* | | | |
Dianthus Therapeutics, Inc.* | | | |
| | | |
Dynavax Technologies Corp.* | | | |
| | | |
| | | |
Elevation Oncology, Inc.* | | | |
Eliem Therapeutics, Inc.* | | | |
Enanta Pharmaceuticals, Inc.* | | | |
Entrada Therapeutics, Inc.* | | | |
| | | |
| | | |
Fennec Pharmaceuticals, Inc.* | | | |
| | | |
Foghorn Therapeutics, Inc.* | | | |
| | |
| | | |
Galectin Therapeutics, Inc.* | | | |
| | | |
| | | |
Greenwich Lifesciences, Inc.* | | | |
| | | |
Halozyme Therapeutics, Inc.* | | | |
Heron Therapeutics, Inc.* (a) | | | |
| | | |
| | | |
Ideaya Biosciences, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
Inhibrx Biosciences, Inc.* | | | |
| | | |
| | | |
Inovio Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
Intellia Therapeutics, Inc.* | | | |
| | | |
Iovance Biotherapeutics, Inc.* | | | |
Ironwood Pharmaceuticals, Inc.* | | | |
iTeos Therapeutics, Inc.* | | | |
Janux Therapeutics, Inc.* | | | |
Jasper Therapeutics, Inc.* | | | |
KalVista Pharmaceuticals, Inc.* | | | |
Keros Therapeutics, Inc.* | | | |
Kiniksa Pharmaceuticals International PLC* | | | |
| | | |
| | | |
| | | |
| | | |
Kymera Therapeutics, Inc.* | | | |
Kyverna Therapeutics, Inc.* | | | |
Larimar Therapeutics, Inc.* | | | |
| | | |
Lexeo Therapeutics, Inc.* | | | |
Lexicon Pharmaceuticals, Inc.* | | | |
Lineage Cell Therapeutics, Inc.* | | | |
Lyell Immunopharma, Inc.* | | | |
| | | |
Madrigal Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
Mersana Therapeutics, Inc.* | | | |
| | | |
Mineralys Therapeutics, Inc.* | | | |
Mirum Pharmaceuticals, Inc.* | | | |
The accompanying notes are an integral part of the financial statements.
| | |
Monte Rosa Therapeutics, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Nurix Therapeutics, Inc.* | | | |
| | | |
| | | |
Olema Pharmaceuticals, Inc.* | | | |
Organogenesis Holdings, Inc.* | | | |
ORIC Pharmaceuticals, Inc.* | | | |
Outlook Therapeutics, Inc.* | | | |
| | | |
| | | |
Perspective Therapeutics, Inc.* | | | |
Poseida Therapeutics, Inc.* | | | |
Praxis Precision Medicines, Inc.* | | | |
| | | |
Prelude Therapeutics, Inc.* | | | |
| | | |
| | | |
Protagonist Therapeutics, Inc.* | | | |
| | | |
| | | |
Puma Biotechnology, Inc.* | | | |
| | | |
| | | |
| | | |
Recursion Pharmaceuticals, Inc. "A"* | | | |
| | | |
Regulus Therapeutics, Inc.* | | | |
Relay Therapeutics, Inc.* | | | |
| | | |
| | | |
REVOLUTION Medicines, Inc.* | | | |
Rhythm Pharmaceuticals, Inc.* | | | |
Rigel Pharmaceuticals, Inc.* | | | |
Rocket Pharmaceuticals, Inc.* | | | |
| | | |
Sana Biotechnology, Inc.* | | | |
| | | |
Scholar Rock Holding Corp.* | | | |
Sera Prognostics, Inc. "A"* | | | |
| | | |
| | | |
Soleno Therapeutics, Inc.* | | | |
| | | |
| | |
SpringWorks Therapeutics, Inc.* | | | |
Spyre Therapeutics, Inc.* | | | |
Stoke Therapeutics, Inc.* | | | |
Summit Therapeutics, Inc.* (a) | | | |
| | | |
Syndax Pharmaceuticals, Inc.* | | | |
Tango Therapeutics, Inc.* | | | |
Taysha Gene Therapies, Inc.* | | | |
Tenaya Therapeutics, Inc.* | | | |
| | | |
| | | |
Travere Therapeutics, Inc.* | | | |
TScan Therapeutics, Inc.* | | | |
| | | |
| | | |
| | | |
Vanda Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Verve Therapeutics, Inc.* | | | |
| | | |
Viridian Therapeutics, Inc.* | | | |
Voyager Therapeutics, Inc.* | | | |
Werewolf Therapeutics, Inc.* | | | |
X4 Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
| | | |
Y-mAbs Therapeutics, Inc.* | | | |
Zentalis Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
| | | |
Health Care Equipment & Supplies 3.4% | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Integra LifeSciences Holdings Corp.* | | | |
| | | |
iRhythm Technologies, Inc.* | | | |
| | | |
| | | |
| | | |
Merit Medical Systems, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
OraSure Technologies, Inc.* | | | |
Orchestra BioMed Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
PROCEPT BioRobotics Corp.* | | | |
| | | |
Pulse Biosciences, Inc.* (a) | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Tactile Systems Technology, Inc.* | | | |
Tandem Diabetes Care, Inc.* | | | |
| | | |
Treace Medical Concepts, Inc.* | | | |
| | | |
Utah Medical Products, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Health Care Providers & Services 2.8% | |
| | | |
| | | |
| | | |
| | | |
AirSculpt Technologies, Inc.* | | | |
| | |
Alignment Healthcare, Inc.* | | | |
AMN Healthcare Services, Inc.* | | | |
| | | |
Aveanna Healthcare Holdings, Inc.* | | | |
BrightSpring Health Services, Inc.* | | | |
Brookdale Senior Living, Inc.* | | | |
Castle Biosciences, Inc.* | | | |
Community Health Systems, Inc.* | | | |
| | | |
Cross Country Healthcare, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Hims & Hers Health, Inc.* | | | |
InfuSystem Holdings, Inc.* | | | |
| | | |
LifeStance Health Group, Inc.* | | | |
| | | |
| | | |
National HealthCare Corp. | | | |
| | | |
| | | |
| | | |
Option Care Health, Inc.* | | | |
| | | |
| | | |
Patterson Companies, Inc. | | | |
Pediatrix Medical Group, Inc.* | | | |
Performant Financial Corp.* | | | |
| | | |
Privia Health Group, Inc.* | | | |
| | | |
Quipt Home Medical Corp.* | | | |
| | | |
Select Medical Holdings Corp. | | | |
Sonida Senior Living, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
U.S. Physical Therapy, Inc. | | | |
| | | |
| | | |
Health Care Technology 0.3% | |
Definitive Healthcare Corp.* | | | |
Evolent Health, Inc. "A"* | | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Life Sciences Tools & Services 0.3% | |
Adaptive Biotechnologies Corp.* | | | |
| | | |
| | | |
| | | |
| | | |
Conduit Pharmaceuticals, Inc.* | | | |
| | | |
| | | |
Harvard Bioscience, Inc.* | | | |
Lifecore Biomedical, Inc.* | | | |
Maravai LifeSciences Holdings, Inc. "A"* | | | |
| | | |
| | | |
Nautilus Biotechnology, Inc.* | | | |
| | | |
Pacific Biosciences of California, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| |
Alimera Sciences, Inc.Common St* | | | |
| | | |
Amneal Pharmaceuticals, Inc.* | | | |
Amphastar Pharmaceuticals, Inc.* | | | |
ANI Pharmaceuticals, Inc.* | | | |
Aquestive Therapeutics, Inc.* | | | |
| | | |
Atea Pharmaceuticals, Inc.* | | | |
Avadel Pharmaceuticals PLC* | | | |
Axsome Therapeutics, Inc.* | | | |
| | | |
Cassava Sciences, Inc.* (a) | | | |
Collegium Pharmaceutical, Inc.* | | | |
Contineum Therapeutics, Inc. "A"* | | | |
Corcept Therapeutics, Inc.* | | | |
| | |
| | | |
Edgewise Therapeutics, Inc.* | | | |
Enliven Therapeutics, Inc.* (a) | | | |
Esperion Therapeutics, Inc.* | | | |
| | | |
EyePoint Pharmaceuticals, Inc.* | | | |
Fulcrum Therapeutics, Inc.* | | | |
Harmony Biosciences Holdings, Inc.* | | | |
| | | |
| | | |
Ligand Pharmaceuticals, Inc.* | | | |
| | | |
Longboard Pharmaceuticals, Inc.* | | | |
| | | |
Mind Medicine MindMed, Inc.* | | | |
| | | |
Neumora Therapeutics, Inc.* | | | |
| | | |
Ocular Therapeutix, Inc.* (a) | | | |
| | | |
Pacira BioSciences, Inc.* | | | |
Phathom Pharmaceuticals, Inc.* (a) | | | |
Phibro Animal Health Corp. "A" | | | |
Pliant Therapeutics, Inc.* | | | |
Prestige Consumer Healthcare, Inc.* | | | |
Revance Therapeutics, Inc.* | | | |
| | | |
| | | |
| | | |
Supernus Pharmaceuticals, Inc.* | | | |
Tarsus Pharmaceuticals, Inc.* | | | |
Terns Pharmaceuticals, Inc.* | | | |
Theravance Biopharma, Inc.* | | | |
Third Harmonic Bio, Inc.* | | | |
Trevi Therapeutics, Inc.* | | | |
Ventyx Biosciences, Inc.* | | | |
Verrica Pharmaceuticals, Inc.* (a) | | | |
| | | |
Xeris Biopharma Holdings, Inc.* | | | |
Zevra Therapeutics, Inc.* | | | |
| | | |
| |
| |
| | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
Archer Aviation, Inc. "A"* (a) | | | |
| | | |
Byrna Technologies, Inc.* | | | |
| | | |
| | | |
| | | |
Intuitive Machines, Inc.* | | | |
Kratos Defense & Security Solutions, Inc.* | | | |
| | | |
| | | |
| | | |
National Presto Industries, Inc. | | | |
| | | |
| | | |
Rocket Lab USA, Inc.* (a) | | | |
| | | |
| | | |
| | | |
Virgin Galactic Holdings, Inc.* | | | |
| | | |
| | | |
Air Freight & Logistics 0.2% | |
Air Transport Services Group, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
Gibraltar Industries, Inc.* | | | |
| | | |
| | | |
Janus International Group, Inc.* | | | |
| | | |
| | | |
Quanex Building Products Corp. | | | |
Resideo Technologies, Inc.* | | | |
| | | |
| | | |
Zurn Elkay Water Solutions Corp. | | | |
| | | |
Commercial Services & Supplies 1.7% | |
| | | |
| | | |
| | | |
| | |
Aris Water Solutions, Inc. "A" | | | |
Bridger Aerospace Group Holdings, Inc.* | | | |
BrightView Holdings, Inc.* | | | |
Casella Waste Systems, Inc. "A"* | | | |
CECO Environmental Corp.* | | | |
| | | |
CompX International, Inc. | | | |
| | | |
| | | |
Driven Brands Holdings, Inc.* | | | |
| | | |
| | | |
Healthcare Services Group, Inc.* | | | |
| | | |
| | | |
| | | |
Liquidity Services, Inc.* | | | |
Matthews International Corp. "A" | | | |
| | | |
Montrose Environmental Group, Inc.* | | | |
| | | |
| | | |
Perma-Fix Environmental Services, Inc.* | | | |
| | | |
| | | |
Quest Resource Holding Corp.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Construction & Engineering 1.5% | |
| | | |
| | | |
| | | |
Bowman Consulting Group Ltd.* | | | |
| | | |
Concrete Pumping Holdings, Inc.* | | | |
Construction Partners, Inc. "A"* | | | |
| | | |
| | | |
Granite Construction, Inc. | | | |
Great Lakes Dredge & Dock Corp.* | | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
Orion Group Holdings, Inc.* | | | |
| | | |
Southland Holdings, Inc.* | | | |
Sterling Infrastructure, Inc.* | | | |
| | | |
| | | |
Electrical Equipment 1.6% | |
| | | |
American Superconductor Corp.* | | | |
Amprius Technologies, Inc.* | | | |
Array Technologies, Inc.* | | | |
| | | |
| | | |
Bloom Energy Corp. "A"* (a) | | | |
ChargePoint Holdings, Inc.* | | | |
| | | |
Energy Vault Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
GrafTech International, Ltd.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Preformed Line Products Co. | | | |
| | | |
Shoals Technologies Group, Inc. "A"* | | | |
SolarMax Technology, Inc.* | | | |
| | | |
| | | |
| | | |
Thermon Group Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
Ground Transportation 0.5% | |
| | | |
Covenant Logistics Group, Inc. | | | |
FTAI Infrastructure, Inc. | | | |
| | | |
| | |
Hertz Global Holdings, Inc.* | | | |
| | | |
P.A.M. Transportation Services, Inc.* | | | |
| | | |
Universal Logistics Holdings, Inc. | | | |
| | | |
| | | |
Industrial Conglomerates 0.0% | |
Brookfield Business Corp. "A" | | | |
| |
| | | |
| |
| | | |
| | | |
| | | |
Albany International Corp. "A" | | | |
| | | |
Atmus Filtration Technologies, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
Commercial Vehicle Group, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Franklin Electric Co., Inc. | | | |
| | | |
| | | |
| | | |
Greenbrier Companies, Inc. | | | |
Helios Technologies, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
John Bean Technologies Corp. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Mayville Engineering Co., Inc.* | | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
Mueller Water Products, Inc. "A" | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Standex International Corp. | | | |
| | | |
| | | |
| | | |
| | | |
Titan International, Inc.* | | | |
| | | |
| | | |
| | | |
Watts Water Technologies, Inc. "A" | | | |
| | | |
Marine Transportation 0.3% | |
| | | |
Genco Shipping & Trading Ltd. | | | |
| | | |
| | | |
| | | |
Pangaea Logistics Solutions Ltd. | | | |
| | | |
| | | |
| |
| | | |
Blade Air Mobility, Inc.* | | | |
Frontier Group Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Sun Country Airlines Holdings, Inc.* | | | |
Wheels Up Experience, Inc.* | | | |
| | | |
Professional Services 2.3% | |
| | | |
| | | |
Barrett Business Services, Inc. | | | |
Blacksky Technology, Inc.* | | | |
| | | |
| | | |
| | | |
| | |
CSG Systems International, Inc. | | | |
| | | |
ExlService Holdings, Inc.* | | | |
| | | |
| | | |
FiscalNote Holdings, Inc.* (a) | | | |
Forrester Research, Inc.* | | | |
| | | |
Heidrick & Struggles International, Inc. | | | |
| | | |
Huron Consulting Group, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Resources Connection, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Trading Companies & Distributors 2.2% | |
Alta Equipment Group, Inc. | | | |
Applied Industrial Technologies, Inc. | | | |
Beacon Roofing Supply, Inc.* | | | |
| | | |
| | | |
Custom Truck One Source, Inc.* | | | |
Distribution Solutions Group, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
H&E Equipment Services, Inc. | | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
Hudson Technologies, Inc.* | | | |
| | | |
| | | |
| | | |
Rush Enterprises, Inc. "A" | | | |
Rush Enterprises, Inc. "B" | | | |
| | | |
| | | |
Willis Lease Finance Corp. | | | |
| | | |
| | | |
Transportation Infrastructure 0.0% | |
| | | |
Information Technology 13.0% | |
Communications Equipment 0.6% | |
| | | |
Applied Optoelectronics, Inc.* | | | |
| | | |
| | | |
| | | |
CommScope Holding Co., Inc.* | | | |
Digi International, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Ribbon Communications, Inc.* | | | |
| | | |
| | | |
| | | |
Electronic Equipment, Instruments & Components 3.0% | |
| | | |
Advanced Energy Industries, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Benchmark Electronics, Inc. | | | |
Climb Global Solutions, Inc. | | | |
| | | |
| | | |
| | | |
Evolv Technologies Holdings, Inc.* | | | |
| | | |
| | | |
Insight Enterprises, Inc.* | | | |
| | |
| | | |
| | | |
Kimball Electronics, Inc.* | | | |
| | | |
| | | |
Methode Electronics, Inc. | | | |
| | | |
Mirion Technologies, Inc.* | | | |
Napco Security Technologies, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Richardson Electronics Ltd. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Vishay Intertechnology, Inc. | | | |
Vishay Precision Group, Inc.* | | | |
| | | |
| |
Applied Digital Corp.* (a) | | | |
| | | |
BigBear.ai Holdings, Inc.* (a) | | | |
BigCommerce Holdings, Inc.Series 1* | | | |
| | | |
| | | |
DigitalOcean Holdings, Inc.* | | | |
| | | |
Grid Dynamics Holdings, Inc.* | | | |
Information Services Group, Inc. | | | |
| | | |
Rackspace Technology, Inc.* | | | |
| | | |
| | | |
Thoughtworks Holding, Inc.* | | | |
| | | |
| | | |
| | | |
Semiconductors & Semiconductor Equipment 2.6% | |
| | | |
| | | |
Alpha & Omega Semiconductor Ltd.* | | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
Axcelis Technologies, Inc.* | | | |
| | | |
| | | |
Credo Technology Group Holding Ltd.* | | | |
| | | |
Everspin Technologies, Inc.* | | | |
| | | |
GCT Semiconductor Holding, Inc.* | | | |
| | | |
| | | |
indie Semiconductor, Inc. "A"* | | | |
Kulicke & Soffa Industries, Inc. | | | |
| | | |
Navitas Semiconductor Corp.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Silicon Laboratories, Inc.* | | | |
| | | |
SkyWater Technology, Inc.* | | | |
SMART Global Holdings, Inc.* | | | |
| | | |
Ultra Clean Holdings, Inc.* | | | |
| | | |
| | | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
Alarm.com Holdings, Inc.* | | | |
| | | |
Altair Engineering, Inc. "A"* | | | |
American Software, Inc. "A" | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Clearwater Analytics Holdings, Inc. "A"* | | | |
| | | |
Consensus Cloud Solutions, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
E2open Parent Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
iLearningEngines Holdings, Inc.* | | | |
Instructure Holdings, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Marathon Digital Holdings, Inc.* (a) | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Pagaya Technologies Ltd. "A"* | | | |
| | | |
| | | |
PowerSchool Holdings, Inc. "A"* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
Riot Platforms, Inc.* (a) | | | |
| | | |
Sapiens International Corp. NV | | | |
SEMrush Holdings, Inc. "A"* | | | |
| | | |
SoundHound AI, Inc. "A"* (a) | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Viant Technology, Inc. "A"* | | | |
Weave Communications, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
Zeta Global Holdings Corp. "A"* | | | |
| | | |
| | | |
Technology Hardware, Storage & Peripherals 0.2% | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| |
Advanced Emissions Solutions, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| | | |
| | | |
Core Molding Technologies, Inc.* | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Minerals Technologies, Inc. | | | |
Northern Technologies International Corp. | | | |
| | | |
| | | |
PureCycle Technologies, Inc.* (a) | | | |
| | | |
Rayonier Advanced Materials, Inc.* | | | |
Sensient Technologies Corp. | | | |
| | | |
| | | |
| | | |
| | | |
Construction Materials 0.4% | |
| | | |
| | | |
Summit Materials, Inc. "A"* | | | |
United States Lime & Minerals, Inc. | | | |
| | | |
Containers & Packaging 0.3% | |
Ardagh Metal Packaging SA | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
Alpha Metallurgical Resources, Inc. | | | |
| | | |
Caledonia Mining Corp. PLC | | | |
Carpenter Technology Corp. | | | |
| | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
Compass Minerals International, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
Haynes International, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Metals Acquisition Ltd. "A"* | | | |
Novagold Resources, Inc.* | | | |
| | | |
Perpetua Resources Corp.* | | | |
| | | |
| | | |
Ramaco Resources, Inc. "A" | | | |
Ramaco Resources, Inc. "B" | | | |
| | | |
| | | |
| | | |
| | | |
Universal Stainless & Alloy Products, Inc.* | | | |
| | | |
| | | |
| | | |
Paper & Forest Products 0.1% | |
| | | |
| | | |
| | | |
| |
| |
Alexander & Baldwin, Inc. | | | |
Alpine Income Property Trust, Inc. | | | |
American Assets Trust, Inc. | | | |
Armada Hoffler Properties, Inc. | | | |
Broadstone Net Lease, Inc. | | | |
| | | |
Empire State Realty Trust, Inc. "A" | | | |
Essential Properties Realty Trust, Inc. | | | |
Gladstone Commercial Corp. | | | |
| | | |
NexPoint Diversified Real Estate Trust | | | |
One Liberty Properties, Inc. | | | |
| | | |
| | |
| |
American Healthcare REIT, Inc. | | | |
| | | |
Community Healthcare Trust, Inc. | | | |
Diversified Healthcare Trust | | | |
Global Medical REIT, Inc. | | | |
| | | |
National Health Investors, Inc. | | | |
Sabra Health Care REIT, Inc. | | | |
Strawberry Fields REIT, Inc. | | | |
Universal Health Realty Income Trust | | | |
| | | |
Hotel & Resort REITs 0.8% | |
Apple Hospitality REIT, Inc. | | | |
Braemar Hotels & Resorts, Inc. | | | |
| | | |
DiamondRock Hospitality Co. | | | |
| | | |
| | | |
Ryman Hospitality Properties, Inc. | | | |
| | | |
Summit Hotel Properties, Inc. | | | |
Sunstone Hotel Investors, Inc. | | | |
Xenia Hotels & Resorts, Inc. | | | |
| | | |
| |
Industrial Logistics Properties Trust | | | |
Innovative Industrial Properties, Inc. | | | |
| | | |
Plymouth Industrial REIT, Inc. | | | |
| | | |
| | | |
| |
| | | |
| | | |
| | | |
| | | |
Easterly Government Properties, Inc. | | | |
| | | |
Franklin Street Properties Corp. | | | |
Hudson Pacific Properties, Inc. | | | |
| | | |
NET Lease Office Properties | | | |
| | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| | | |
Piedmont Office Realty Trust, Inc. "A" | | | |
Postal Realty Trust, Inc. "A" | | | |
SL Green Realty Corp. (a) | | | |
| | | |
Real Estate Management & Development 0.7% | |
American Realty Investors, Inc.* | | | |
Anywhere Real Estate, Inc.* | | | |
| | | |
| | | |
DigitalBridge Group, Inc. | | | |
| | | |
| | | |
| | | |
Kennedy-Wilson Holdings, Inc. | | | |
| | | |
Maui Land & Pineapple Co., Inc.* | | | |
| | | |
Offerpad Solutions, Inc.* | | | |
Opendoor Technologies, Inc.* | | | |
RE/MAX Holdings, Inc. "A" | | | |
| | | |
| | | |
| | | |
Stratus Properties, Inc.* | | | |
| | | |
| | | |
| | | |
Transcontinental Realty Investors, Inc.* | | | |
| | | |
| |
Apartment Investment and Management Co. "A" * | | | |
| | | |
| | | |
| | | |
| | | |
Independence Realty Trust, Inc. | | | |
NexPoint Residential Trust, Inc. | | | |
| | | |
| | | |
| | | |
| |
| | | |
| | | |
Cbl & Associates Properties, Inc. | | | |
| | | |
| | |
Inventrust Properties Corp. | | | |
| | | |
| | | |
Phillips Edison & Co., Inc. | | | |
Retail Opportunity Investments Corp. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
Four Corners Property Trust, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| |
| | | |
| | | |
Hawaiian Electric Industries, Inc. | | | |
| | | |
| | | |
| | | |
Portland General Electric Co. | | | |
| | | |
| |
Brookfield Infrastructure Corp. "A" | | | |
Chesapeake Utilities Corp. | | | |
New Jersey Resources Corp. | | | |
Northwest Natural Holding Co. | | | |
| | | |
| | | |
Southwest Gas Holdings, Inc. | | | |
| | | |
| | | |
Independent Power & Renewable Electricity Producers 0.2% | |
| | | |
Montauk Renewables, Inc.* | | | |
| | | |
Sunnova Energy International, Inc.* | | | |
| | | |
The accompanying notes are an integral part of the financial statements.
| | |
| |
| | | |
| | | |
Northwestern Energy Group, Inc. | | | |
| | | |
| | | |
| |
American States Water Co. | | | |
| | | |
California Water Service Group | | | |
Consolidated Water Co., Ltd. | | | |
Global Water Resources, Inc. | | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Total Common Stocks (Cost $350,336,024) | |
| |
| |
Life Sciences Tools & Services 0.0% | |
OmniAb, Inc. $12.50 Earnout* (b) (c) | | | |
OmniAb, Inc. $15.00 Earnout* (b) (c) | | | |
Total Other Investments (Cost $0) | |
| |
| |
| | | |
Cartesian Therapeutics, Inc.* (b) | | | |
Chinook Therapeutics, Inc.* (b) | | | |
| | | |
| | |
| | | |
Tobira Therapeutics, Inc.* (b) | | | |
Total Rights (Cost $9,317) | | | |
| |
| |
Danimer Scientific, Inc., Expiration Date 5/3/2029* (b) (Cost $0) | | | |
| | |
Government & Agency Obligations 0.1% |
U.S. Treasury Obligations | |
U.S. Treasury Bills, 5.18% (d), 10/3/2024 (e) (Cost $315,661) | | | |
| | |
Securities Lending Collateral 2.4% |
DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", 5.24% (f) (g) (Cost $9,657,355) | | | |
|
DWS Central Cash Management Government Fund, 5.36% (f) (Cost $4,268,775) | | | |
| | | |
Total Investment Portfolio (Cost $364,587,132) | | | |
Other Assets and Liabilities, Net | | | |
| | | |
The accompanying notes are an integral part of the financial statements.
A summary of the Fund’s transactions with affiliated investments during the period ended June 30, 2024 are as follows:
| | | Net Realized
Gain/
(Loss) ($) | Net Change in
Unrealized
Appreciation
(Depreciation) ($) | | Capital Gain
Distributions ($) | Number
of Shares
at
6/30/2024 | |
Securities Lending Collateral 2.4% |
DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares",
5.24% (f) (g) |
| | | | | | | | |
|
DWS Central Cash Management Government Fund, 5.36% (f) |
| | | | | | | | |
| | | | | | | | |
| Non-income producing security. |
| All or a portion of these securities were on loan. In addition, "Other Assets and Liabilities, Net" are including pending sales amounting to $3,188,606 that are also on loan (see Notes to Financial Statements). The value of securities loaned at June 30, 2024 amounted to $5,682,078, which is 1.5% of net assets. |
| Investment was valued using significant unobservable inputs. |
| Earnout Shares: Will vest based upon the achievement of certain volume-weighted average trading prices (VWAP) for shares of OmniAb Inc. Earnout Shares are not transferrable until the vesting condition for the applicable tranche of Earnout Shares has been achieved. |
| Annualized yield at time of purchase; not a coupon rate. |
| At June 30, 2024, this security has been pledged, in whole or in part, to cover initial margin requirements for open futures contracts. |
| Affiliated fund managed by DWS Investment Management Americas, Inc. The rate shown is the annualized seven-day yield at period end. |
| Represents cash collateral held in connection with securities lending. Income earned by the Fund is net of borrower rebates. |
| Represents the net increase (purchase cost) or decrease (sales proceeds) in the amount invested in cash collateral for the period ended June 30, 2024. |
REG S: Securities sold under Regulation S may not be offered, sold or delivered within the United States or to, or for the account or benefit of, U.S. persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act of 1933. |
REIT: Real Estate Investment Trust |
At June 30, 2024, open futures contracts purchased were as follows:
| | | | | | Unrealized
Appreciation ($) |
Russell E-Mini 2000 Index | | | | | | |
For information on the Fund’s policy and additional disclosures regarding futures contracts, please refer to the Derivatives section of Note B in the accompanying Notes to Financial Statements.
The accompanying notes are an integral part of the financial statements.
Fair Value Measurements
Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds and credit risk). Level 3 includes significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.
The following is a summary of the inputs used as of June 30, 2024 in valuing the Fund's investments. For information on the Fund's policy regarding the valuation of investments, please refer to the Security Valuation section of Note A in the accompanying Notes to Financial Statements.
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
Government & Agency Obligations | | | | |
Short-Term Investments (a) | | | | |
| | | | |
| | | | |
| | | | |
| See Investment Portfolio for additional detailed categorizations. |
| Derivatives include unrealized appreciation (depreciation) on open futures contracts. |
The accompanying notes are an integral part of the financial statements.
Statement ofAssets and Liabilities as of June 30, 2024 (Unaudited)
| |
Investments in non-affiliated securities, at value (cost $350,661,002) — including $5,682,078 of securities loaned | |
Investment in DWS Government & Agency Securities Portfolio (cost $9,657,355)* | |
Investment in DWS Central Cash Management Government Fund (cost $4,268,775) | |
| |
Receivable for investments sold | |
Receivable for Fund shares sold | |
| |
Affiliated securities lending income receivable | |
Receivable for variation margin on futures contracts | |
| |
| |
| |
Payable upon return of securities loaned | |
Payable for investments purchased | |
Payable for Fund shares redeemed | |
| |
| |
Other accrued expenses and payables | |
| |
| |
| |
Distributable earnings (loss) | |
| |
| |
| |
| |
Net Asset Value, offering and redemption price per share ($360,681,724 ÷ 27,187,554 outstanding shares of beneficial interest, no par value, unlimited number of shares authorized) | |
| |
Net Asset Value, offering and redemption price per share ($31,303,876 ÷ 2,356,249 outstanding shares of beneficial interest, no par value, unlimited number of shares authorized) | |
| Represents collateral on securities loaned. |
for the six months ended June 30, 2024 (Unaudited)
| |
| |
Dividends (net of foreign taxes withheld of $4,427) | |
| |
Income distributions — DWS Central Cash Management Government Fund | |
Affiliated securities lending income | |
| |
| |
| |
| |
| |
Record keeping fee (Class B) | |
Distribution service fee (Class B) | |
| |
| |
| |
Trustees' fees and expenses | |
| |
Total expenses before expense reductions | |
| |
Total expenses after expense reductions | |
| |
Realized and Unrealized Gain (Loss) | |
Net realized gain (loss) from: | |
| |
| |
| |
Change in net unrealized appreciation (depreciation) on: | |
| |
| |
| |
| |
Net increase (decrease) in net assets resulting from operations | |
The accompanying notes are an integral part of the financial statements.
Statements of Changes in Net Assets
| Six Months Ended June 30, 2024 | |
Increase (Decrease) in Net Assets | | |
| | |
| | |
| | |
Change in net unrealized appreciation
(depreciation) | | |
Net increase (decrease) in net assets resulting from operations | | |
Distributions to shareholders: | | |
| | |
| | |
| | |
| | |
| | |
Proceeds from shares sold | | |
Reinvestment of distributions | | |
Payments for shares redeemed | | |
Net increase (decrease) in net assets from Class A share transactions | | |
| | |
Proceeds from shares sold | | |
Reinvestment of distributions | | |
Payments for shares redeemed | | |
Net increase (decrease) in net assets from Class B share transactions | | |
Increase (decrease) in net assets | | |
Net assets at beginning of period | | |
Net assets at end of period | | |
| | |
| | |
| | |
Shares outstanding at beginning of period | | |
| | |
Shares issued to shareholders in reinvestment of distributions | | |
| | |
Net increase (decrease) in Class A shares | | |
Shares outstanding at end of period | | |
| | |
Shares outstanding at beginning of period | | |
| | |
Shares issued to shareholders in reinvestment of distributions | | |
| | |
Net increase (decrease) in Class B shares | | |
Shares outstanding at end of period | | |
The accompanying notes are an integral part of the financial statements.
Financial Highlights
DWS Small Cap Index VIP — Class A |
| | |
| | | | | | |
|
Net asset value, beginning of period | | | | | | |
Income (loss) from investment operations: | | | | | | |
| | | | | | |
Net realized and unrealized gain (loss) | | | | | | |
Total from investment operations | | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Net asset value, end of period | | | | | | |
| | | | | | |
Ratios to Average Net Assets and Supplemental Data |
Net assets, end of period ($ millions) | | | | | | |
Ratio of expenses before expense reductions (%)c | | | | | | |
Ratio of expenses after expense reductions (%)c | | | | | | |
Ratio of net investment income (%) | | | | | | |
Portfolio turnover rate (%) | | | | | | |
| Based on average shares outstanding during the period. |
| Total return would have been lower had certain expenses not been reduced. |
| Expense ratio does not reflect charges and fees associated with the separate account that invests in the Fund or any variable life insurance policy or variable annuity contract for which the Fund is an investment option. |
| |
| |
The accompanying notes are an integral part of the financial statements.
DWS Small Cap Index VIP — Class B |
| | |
| | | | | | |
| | | | | | |
Net asset value, beginning of period | | | | | | |
Income (loss) from investment operations: | | | | | | |
| | | | | | |
Net realized and unrealized gain (loss) | | | | | | |
Total from investment operations | | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Net asset value, end of period | | | | | | |
| | | | | | |
Ratios to Average Net Assets and Supplemental Data |
Net assets, end of period ($ millions) | | | | | | |
Ratio of expenses before expense reductions (%)c | | | | | | |
Ratio of expenses after expense reductions (%)c | | | | | | |
Ratio of net investment income (%) | | | | | | |
Portfolio turnover rate (%) | | | | | | |
| Based on average shares outstanding during the period. |
| Total return would have been lower had certain expenses not been reduced. |
| Expense ratio does not reflect charges and fees associated with the separate account that invests in the Fund or any variable life insurance policy or variable annuity contract for which the Fund is an investment option. |
| |
| |
The accompanying notes are an integral part of the financial statements.
Notes to Financial Statements (Unaudited)
A.
Organization and Significant Accounting Policies
Deutsche DWS Investments VIT Funds (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust is organized as a Massachusetts business trust. DWS Small Cap Index VIP (the “Fund”) is a diversified series of the Trust offered to investors. The Fund is an underlying investment vehicle for variable annuity contracts and variable life insurance policies to be offered by the separate accounts of certain life insurance companies (“Participating Insurance Companies”).
Multiple Classes of Shares of Beneficial Interest. The Fund offers two classes of shares (Class A shares and Class B shares). Class B shares are subject to Rule 12b-1 distribution fees under the 1940 Act and recordkeeping fees equal to annual rates of up to 0.25% and of up to 0.15%, respectively, of the average daily net assets of the Class B shares of the Fund. Class A shares are not subject to such fees.
Investment income, realized and unrealized gains and losses, and certain fund-level expenses and expense reductions, if any, are borne pro rata on the basis of relative net assets by the holders of all classes of shares, except that each class bears certain expenses unique to that class (including the applicable 12b-1 distribution fees). Differences in class-level expenses may result in payment of different per share dividends by class. All shares have equal rights with respect to voting subject to class-specific arrangements.
The Fund's financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) which require the use of management estimates. Actual results could differ from those estimates. The Fund qualifies as an investment company under Topic 946 of Accounting Standards Codification of U.S. GAAP. The policies described below are followed consistently by the Fund in the preparation of its financial statements.
Security Valuation. Investments are stated at value determined as of the close of regular trading on the New York Stock Exchange on each day the exchange is open for trading.
The Fund’s Board has designated DWS Investment Management Americas, Inc. (the “Advisor”) as the valuation designee for the Fund pursuant to Rule 2a-5 under the 1940 Act. The Advisor's Pricing Committee (the “Pricing Committee”) typically values securities using readily available market quotations or prices supplied by independent pricing services (which are considered fair values under Rule 2a-5). The Advisor has adopted fair valuation procedures that provide methodologies for fair valuing securities.
Various inputs are used in determining the value of the Fund’s investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds and credit risk). Level 3 includes significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments). The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.
Equity securities are valued at the most recent sale price or official closing price reported on the exchange (U.S. or foreign) or over-the-counter market on which they trade. Securities for which no sales are reported are valued at the calculated mean between the most recent bid and asked quotations on the relevant market or, if a mean cannot be determined, at the most recent bid quotation. Equity securities are generally categorized as Level 1.
Debt securities are valued at prices supplied by independent pricing services approved by the Pricing Committee. Such services may use various pricing techniques which take into account appropriate factors such as yield, quality, coupon rate, maturity, type of issue, trading characteristics, prepayment speeds and other data, as well as broker quotes. If the pricing services are unable to provide valuations, debt securities are valued at the average of the most recent reliable bid quotations or evaluated prices, as applicable, obtained from broker-dealers. These securities are generally categorized as Level 2.
Investments in open-end investment companies are valued at their net asset value each business day and are categorized as Level 1.
Futures contracts are generally valued at the settlement prices established each day on the exchange on which they are traded and are categorized as Level 1.
Securities and other assets for which market quotations are not readily available or for which the above valuation procedures are deemed not to reflect fair value are valued in a manner that is intended to reflect their fair value as determined in accordance with procedures approved by the Pricing Committee and are
generally categorized as Level 3. In accordance with the Fund’s valuation procedures, factors considered in determining value may include, but are not limited to, the type of the security; the size of the holding; the initial cost of the security; the existence of any contractual restrictions on the security’s disposition; the price and extent of public trading in similar securities of the issuer or of comparable companies; quotations or evaluated prices from broker-dealers and/or pricing services; information obtained from the issuer, analysts, and/or the appropriate stock exchange (for exchange-traded securities); an analysis of the company’s or issuer’s financial statements; an evaluation of the forces that influence the issuer and the market(s) in which the security is purchased and sold; and with respect to debt securities, the maturity, coupon, creditworthiness, currency denomination and the movement of the market in which the security is normally traded. The value determined under these procedures may differ from published values for the same securities.
Disclosure about the classification of fair value measurements is included in a table following the Fund's Investment Portfolio.
Securities Lending. Deutsche Bank AG, as securities lending agent, lends securities of the Fund to certain financial institutions under the terms of its securities lending agreement. During the term of the loans, the Fund continues to receive interest and dividends generated by the securities and to participate in any changes in their market value. The Fund requires the borrowers of the securities to maintain collateral with the Fund consisting of either cash or liquid, unencumbered assets having a value at least equal to the value of the securities loaned. When the collateral falls below specified amounts, the securities lending agent will use its best efforts to obtain additional collateral on the next business day to meet required amounts under the securities lending agreement. During the six months ended June 30, 2024, the Fund invested the cash collateral, if any, into a joint trading account in affiliated money market funds, including DWS Government & Agency Securities Portfolio, managed by DWS Investment Management Americas, Inc. DWS Investment Management Americas, Inc. receives a management/administration fee (0.13% annualized effective rate as of June 30, 2024) on the cash collateral invested in DWS Government & Agency Securities Portfolio. The Fund receives compensation for lending its securities either in the form of fees or by earning interest on invested cash collateral net of borrower rebates and fees paid to a securities lending agent. Either the Fund or the borrower may terminate the loan at any time, and the borrower, after notice, is required to return borrowed securities within a standard time period. There may be risks of delay and costs in recovery of securities or even loss of rights in the collateral should the borrower of the securities fail financially. If the Fund is not able to recover securities lent, the Fund may sell the collateral and purchase a replacement investment in the market, incurring the risk that the value of the replacement security is greater than the value of the collateral. The Fund is also subject to all investment risks associated with the reinvestment of any cash collateral received, including, but not limited to, interest rate, credit and liquidity risk associated with such investments.
As of June 30, 2024, the Fund had securities on loan. The value of the related collateral exceeded the value of the securities loaned at period end.
Remaining Contractual Maturity of the Agreements as of June 30, 2024
| | | | | |
Securities Lending Transactions |
| | | | | |
| | | | | |
| | | | | |
Gross amount of recognized liabilities for securities lending transactions: | |
Federal Income Taxes. The Fund is treated as a separate taxpayer as provided for in the Internal Revenue Code of 1986, as amended (the “Code”). It is the Fund's policy to comply with the requirements of the Code, which are applicable to regulated investment companies, and to distribute all of its taxable income to the separate accounts of the Participating Insurance Companies which hold its shares.
At June 30, 2024, the aggregate cost of investments for federal income tax purposes was $370,841,056. The net unrealized appreciation for all investments based on tax cost was $30,671,475. This consisted of aggregate gross unrealized appreciation for all investments for which there was an excess of value over tax
cost of $99,648,172 and aggregate gross unrealized depreciation for all investments for which there was an excess of tax cost over value of $68,976,697.
The Fund has reviewed the tax positions for the open tax years as of December 31, 2023 and has determined that no provision for income tax and/or uncertain tax positions is required in the Fund's financial statements. The Fund's federal tax returns for the prior three fiscal years remain open subject to examination by the Internal Revenue Service.
Distribution of Income and Gains. Distributions from net investment income of the Fund, if any, are declared and distributed to shareholders annually. Net realized gains from investment transactions, in excess of available capital loss carryforwards, would be taxable to the Fund if not distributed, and, therefore, will be distributed to shareholders at least annually. The Fund may also make additional distributions for tax purposes if necessary.
The timing and characterization of certain income and capital gain distributions are determined annually in accordance with federal tax regulations which may differ from accounting principles generally accepted in the United States of America. These differences primarily relate to certain securities sold at a loss, income received from passive foreign investment companies, investments in derivatives, the realized tax character on distributions from certain securities and income related to restructuring of certain securities. As a result, net investment income (loss) and net realized gain (loss) on investment transactions for a reporting period may differ significantly from distributions during such period. Accordingly, the Fund may periodically make reclassifications among certain of its capital accounts without impacting the net asset value of the Fund.
The tax character of current year distributions will be determined at the end of the current fiscal year.
Contingencies. In the normal course of business, the Fund may enter into contracts with service providers that contain general indemnification clauses. The Fund’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet been made. However, based on experience, the Fund expects the risk of loss to be remote.
Expenses. Expenses of the Trust arising in connection with a specific fund are allocated to that fund. Other Trust expenses which cannot be directly attributed to a fund are apportioned among the funds in the Trust based upon the relative net assets or other appropriate measures.
Real Estate Investment Trusts. The Fund at its fiscal year end recharacterizes distributions received from a Real Estate Investment Trust (“REIT”) investment based on information provided by the REIT into the following categories: ordinary income, long-term and short-term capital gains, and return of capital. If information is not available timely from a REIT, the recharacterization will be estimated for financial reporting purposes and a recharacterization will be made to the accounting records in the following year when such information becomes available. Distributions received from REITs in excess of income are recorded as either a reduction of cost of investments or realized gains.
Other. Investment transactions are accounted for on a trade date plus one basis for daily net asset value calculations. However, for financial reporting purposes, investment transactions are reported on trade date. Interest income is recorded on the accrual basis. Dividend income is recorded on the ex-dividend date net of foreign withholding taxes. Realized gains and losses from investment transactions are recorded on an identified cost basis. Proceeds from litigation payments, if any, are included in net realized gain (loss) from investments.
A futures contract is an agreement between a buyer or seller and an established futures exchange or its clearinghouse in which the buyer or seller agrees to take or make a delivery of a specific amount of a financial instrument at a specified price on a specific date (settlement date). For the six months ended June 30, 2024, the Fund invested in futures to keep cash on hand to meet shareholder redemptions or other needs while maintaining exposure to the stock market.
Upon entering into a futures contract, the Fund is required to deposit with a financial intermediary cash or securities (“initial margin”) in an amount equal to a certain percentage of the face value indicated in the futures contract. Subsequent payments (“variation margin”) are made or received by the Fund dependent upon the daily fluctuations in the value and are recorded for financial reporting purposes as unrealized gains or losses by the Fund. Gains or losses are realized when the contract expires or is closed. Since all futures contracts are exchange-traded, counterparty risk is minimized as the exchange’s clearinghouse acts as the counterparty, and guarantees the futures against default.
Certain risks may arise upon entering into futures contracts, including the risk that an illiquid market will limit the Fund's ability to close out a futures contract prior to the settlement date and the risk that the futures contract is not well correlated with the security, index or currency to which it relates. Risk of loss may exceed amounts recognized in the Statement of Assets and Liabilities.
A summary of the open futures contracts as of June 30, 2024, is included in a table following the Fund’s Investment Portfolio. For the six months ended June 30, 2024, the investment in futures contracts purchased had a total notional value generally indicative of a range from approximately $6,298,000 to $7,296,000.
The following table summarizes the value of the Fund's derivative instruments held as of June 30, 2024 and the related location in the accompanying Statement of Assets and Liabilities, presented by primary underlying risk exposure:
| |
| |
The above derivative is located in the following Statement of Assets and Liabilities account: |
| Futures contracts are reported in the table above using cumulative appreciation of futures contracts, as reported in the futures contracts table following the Fund’s Investment Portfolio; within the Statement of Assets and Liabilities, the variation margin at period end is reported as Receivable (Payable) for variation margin on futures contracts. |
Additionally, the amount of unrealized and realized gains and losses on derivative instruments recognized in Fund earnings during the six months ended June 30, 2024 and the related location in the accompanying Statement of Operations is summarized in the following tables by primary underlying risk exposure:
| |
| |
The above derivative is located in the following Statement of Operations account: |
| Net realized gain (loss) from futures contracts |
Change in Net Unrealized Appreciation (Depreciation) | |
| |
The above derivative is located in the following Statement of Operations account: |
| Change in net unrealized appreciation (depreciation) on futures contracts |
C.
Purchases and Sales of Securities
During the six months ended June 30, 2024, purchases and sales of investment securities (excluding short-term investments) aggregated $54,279,726 and $57,339,426, respectively.
Management Agreement. Under the Investment Management Agreement with DWS Investment Management Americas, Inc. (“DIMA” or the “Advisor”), an indirect, wholly owned subsidiary of DWS Group GmbH & Co. KGaA (“DWS Group”), the Advisor determines the securities, instruments and other contracts relating to investments to be purchased, sold or entered into by the Fund or delegates such responsibility to the Fund’s subadvisor. Northern Trust Investments, Inc. (“NTI”) serves as subadvisor. As a subadvisor to the Fund, NTI makes investment decisions and buys and sells securities for the Fund. NTI is paid by the Advisor for the services NTI provides to the Fund.
Under the Investment Management Agreement with the Advisor, the Fund pays the Advisor an annual fee based on the average daily net assets of the Fund, computed and accrued daily and payable monthly at the annual rate (exclusive of any applicable waivers/reimbursements) of 0.28%.
For the period from January 1, 2024 through April 30, 2024, the Advisor had contractually agreed to waive its fees and/or reimburse certain operating expenses of the Fund to the extent necessary to maintain the total annual operating expenses (excluding certain expenses such as extraordinary expenses, taxes, brokerage, interest expense and acquired fund fees and expenses) of each class as follows:
Effective May 1, 2024 through April 30, 2025, the Advisor has contractually agreed to waive its fees and/or reimburse certain operating expenses of the Fund to the extent necessary to maintain the total annual operating expenses (excluding certain expenses such as extraordinary expenses, taxes, brokerage, interest expense and acquired fund fees and expenses) of each class as follows:
For the six months ended June 30, 2024, fees waived and/or expenses reimbursed for each class are as follows:
Administration Fee. Pursuant to an Administrative Services Agreement, DIMA provides most administrative services to the Fund. For all services provided under the Administrative Services Agreement, the Fund pays the Advisor an annual fee (“Administration Fee”) of 0.097% of the Fund’s average daily net assets, computed and accrued daily and payable monthly. For the six months ended June 30, 2024, the Administration Fee was $186,563, of which $31,105 is unpaid.
Distribution Service Agreement. DWS Distributors, Inc. (“DDI”), an affiliate of the Advisor, is the Fund’s distributor. In accordance with the Distribution Plan, DDI receives 12b-1 fees of up to 0.25% of the average daily net assets of Class B shares. For the six months ended June 30, 2024, the Distribution Service Fee was as follows:
Service Provider Fees. DWS Service Company (“DSC”), an affiliate of the Advisor, is the transfer agent, dividend-paying agent and shareholder service agent for the Fund. Pursuant to a sub-transfer agency agreement between DSC and SS&C GIDS, Inc. (“SS&C”), DSC has delegated certain transfer agent, dividend-paying agent and shareholder service agent functions to SS&C. DSC compensates SS&C out of the shareholder servicing fee it receives from the Fund. For the six months ended June 30, 2024, the amounts charged to the Fund by DSC were as follows:
Other Service Fees. Under an agreement with the Fund, DIMA is compensated for providing regulatory filing services to the Fund. For the six months ended June 30, 2024, the amount charged to the Fund by DIMA included in the Statement of Operations under “Reports to shareholders” aggregated $2,185, of which $635 is unpaid.
Trustees’ Fees and Expenses. The Fund paid retainer fees to each Trustee not affiliated with the Advisor, plus specified amounts to the Board Chairperson and to each committee Chairperson.
Affiliated Cash Management Vehicles. The Fund may invest uninvested cash balances in DWS Central Cash Management Government Fund and DWS ESG Liquidity Fund, affiliated money market funds which are managed by the Advisor. Each affiliated money market fund is managed in accordance with Rule 2a-7 under the 1940 Act, which governs the quality, maturity, diversity and liquidity of instruments in which a money market fund may invest. DWS Central Cash Management Government Fund seeks to maintain a stable net asset value, and DWS ESG Liquidity Fund maintains a floating net asset value. The Fund indirectly bears its proportionate share of the expenses of each affiliated money market fund in which it invests. DWS Central Cash Management Government Fund does not pay the Advisor an investment management fee. To the extent that DWS ESG Liquidity Fund pays an investment management fee to the Advisor, the Advisor will
waive an amount of the investment management fee payable to the Advisor by the Fund equal to the amount of the investment management fee payable on the Fund’s assets invested in DWS ESG Liquidity Fund.
Securities Lending Agent Fees. Deutsche Bank AG serves as securities lending agent for the Fund. For the six months ended June 30, 2024, the Fund incurred securities lending agent fees to Deutsche Bank AG in the amount of $14,311.
At June 30, 2024, four participating insurance companies were owners of record of 10% or more of the total outstanding Class A shares of the Fund, each owning 32%,20%, 13% and 11%, respectively. Three participating insurance companies were owners of record of 10% or more of the total outstanding Class B shares of the Fund, each owning 42%, 23% and 19%, respectively.
The Fund and other affiliated funds (the “Participants”) share in a $345 million revolving credit facility provided by a syndication of banks. The Fund may borrow for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities. The Participants are charged an annual commitment fee, which is allocated based on net assets, among each of the Participants. Interest is calculated at a daily fluctuating rate per annum equal to the sum of 0.10% plus the higher of the Federal Funds Effective Rate and the Overnight Bank Funding Rate, plus 1.25%. The Fund may borrow up to a maximum of 33 percent of its net assets under the agreement. The Fund had no outstanding loans at June 30, 2024.
Advisory Agreement Board Considerations and Fee Evaluation
The Board of Trustees (hereinafter referred to as the “Board” or “Trustees”) approved the renewal of DWS Small Cap Index VIP's (the “Fund”) investment management agreement (the “Agreement”) with DWS Investment Management Americas, Inc. (“DIMA”) and sub-advisory agreement (the “Sub-Advisory Agreement” and together with the Agreement, the “Agreements”) between DIMA and Northern Trust Investments, Inc. (“NTI”) in September 2023.
In terms of the process that the Board followed prior to approving the Agreements, shareholders should know that:
—
During the entire process, all of the Fund's Trustees were independent of DIMA and its affiliates (the “Independent Trustees”).
—
The Board met frequently during the past year to discuss fund matters and dedicated a substantial amount of time to contract review matters. Over the course of several months, the Board reviewed extensive materials received from DIMA, independent third parties and independent counsel. These materials included an analysis of the Fund’s performance, fees and expenses, profitability, economies of scale, and fall-out benefits from a fee consultant retained by the Fund’s Independent Trustees (the “Fee Consultant”).
—
The Board also received extensive information throughout the year regarding performance of the Fund.
—
The Independent Trustees regularly met privately with counsel to discuss contract review and other matters. In addition, the Independent Trustees were advised by the Fee Consultant as part of their review of the Fund's contractual arrangements and considered a comprehensive report prepared by the Fee Consultant in connection with their deliberations.
—
In connection with reviewing the Agreements, the Board also reviewed the terms of the Fund's Rule 12b-1 plan, distribution agreement, administrative services agreement, transfer agency agreement and other material service agreements.
In connection with the contract review process, the Board considered the factors discussed below, among others. The Board also considered that DIMA and its predecessors have managed the Fund since its inception, and the Board believes that a long-term relationship with a capable, conscientious advisor is in the best interests of the Fund. The Board considered, generally, that shareholders chose to invest or remain invested in the Fund knowing that DIMA managed the Fund. DIMA is part of DWS Group GmbH & Co. KGaA (“DWS Group”). DWS Group is a global asset management business that offers a wide range of investing expertise and resources, including research capabilities in many countries throughout the world. DWS Group is majority-owned by Deutsche Bank AG, with approximately 20% of its shares publicly traded.
As part of the contract review process, the Board carefully considered the fees and expenses of each DWS fund overseen by the Board in light of the fund’s performance. In many cases, this led to the negotiation and implementation of expense caps.
While shareholders may focus primarily on fund performance and fees, the Fund’s Board considers these and many other factors, including the quality and integrity of DIMA’s and NTI’s personnel and administrative support services provided by DIMA, such as back-office operations, fund valuations, and compliance policies and procedures.
Nature, Quality and Extent of Services. The Board considered the terms of the Agreements, including the scope of advisory services provided under the Agreements. The Board noted that, under the Agreements, DIMA and NTI provide portfolio management services to the Fund and that, pursuant to a separate administrative services agreement, DIMA provides administrative services to the Fund. The Board considered the experience and skills of senior management and investment personnel and the resources made available to such personnel. The Board also considered the risks to DIMA in sponsoring or managing the Fund, including financial, operational and reputational risks, the potential economic impact to DIMA from such risks and DIMA’s approach to addressing such risks. Throughout the course of the year, the Board also received information regarding DIMA’s oversight of fund sub-advisors, including NTI. The Board reviewed the Fund’s performance over short-term and long-term periods and compared those returns to various agreed-upon performance measures, including market index(es) and a peer universe compiled using information supplied by Morningstar Direct (“Morningstar”), an independent fund data service. The Board also noted that it has put into place a process of identifying “Funds in Review” (e.g., funds performing poorly relative to a peer universe), and receives additional reporting from DIMA regarding such funds and, where appropriate, DIMA’s plans to address underperformance. The Board believes this process is an effective manner of identifying and addressing underperforming funds. Based on the information provided, the Board noted that,
for the one-, three- and five-year periods ended December 31, 2022, the Fund’s performance (Class A shares) was in the 4th quartile, 3rd quartile and 3rd quartile, respectively, of the applicable Morningstar universe (the 1st quartile being the best performers and the 4th quartile being the worst performers).
Fees and Expenses. The Board considered the Fund’s investment management fee schedule, sub-advisory fee schedule, operating expenses and total expense ratios, and comparative information provided by Broadridge Financial Solutions, Inc. (“Broadridge”) and the Fee Consultant regarding investment management fee rates paid to other investment advisors by similar funds (1st quartile being the most favorable and 4th quartile being the least favorable). With respect to management fees paid to other investment advisors by similar funds, the Board noted that the contractual fee rates paid by the Fund, which include a 0.097% fee paid to DIMA under the Fund’s administrative services agreement, were higher than the median (4th quartile) of the applicable Broadridge peer group (based on Broadridge data provided as of December 31, 2022). The Board noted that, effective October 1, 2021, in connection with the 2021 contract renewal process, DIMA agreed to reduce the Fund’s contractual management fee by 0.07%. With respect to the sub-advisory fee paid to NTI, the Board noted that the fee is paid by DIMA out of its fee and not directly by the Fund. The Board noted that the Fund’s Class A shares total (net) operating expenses were expected to be higher than the median (3rd quartile) of the applicable Broadridge expense universe (based on Broadridge data provided as of December 31, 2022, and analyzing Broadridge expense universe Class A (net) expenses less any applicable 12b-1 fees) (“Broadridge Universe Expenses”). The Board also reviewed data comparing each other operational share class’s total (net) operating expenses to the applicable Broadridge Universe Expenses. The Board noted that the expense limitations agreed to by DIMA were expected to help the Fund’s total (net) operating expenses remain competitive. The Board considered the Fund’s management fee rate as compared to fees charged by DIMA to comparable DWS U.S. registered funds (“DWS Funds”) and considered differences between the Fund and the comparable DWS Funds. The information requested by the Board as part of its review of fees and expenses also included information about institutional accounts (including any sub-advised funds and accounts) and funds offered primarily to European investors (“DWS Europe Funds”) managed by DWS Group. The Board noted that DIMA indicated that DWS Group does not manage any institutional accounts or DWS Europe Funds comparable to the Fund.
On the basis of the information provided, the Board concluded that management fees were reasonable and appropriate in light of the nature, quality and extent of services provided by DIMA and NTI.
Profitability. The Board reviewed detailed information regarding revenues received by DIMA under the Agreement. The Board considered the estimated costs to DIMA, and pre-tax profits realized by DIMA, from advising the DWS Funds, as well as estimates of the pre-tax profits attributable to managing the Fund in particular. The Board also received information regarding the estimated enterprise-wide profitability of DIMA and its affiliates with respect to all fund services in totality and by fund. The Board and the Fee Consultant reviewed DIMA’s methodology in allocating its costs to the management of the Fund. Based on the information provided, the Board concluded that the pre-tax profits realized by DIMA in connection with the management of the Fund were not unreasonable. The Board also reviewed certain publicly available information regarding the profitability of certain similar investment management firms. The Board noted that, while information regarding the profitability of such firms is limited (and in some cases is not necessarily prepared on a comparable basis), DIMA and its affiliates’ overall profitability with respect to the DWS Funds (after taking into account distribution and other services provided to the funds by DIMA and its affiliates) was lower than the overall profitability levels of most comparable firms for which such data was available. The Board did not consider the profitability of NTI with respect to the Fund. The Board noted that DIMA pays NTI’s fee out of its management fee, and its understanding that the Fund’s sub-advisory fee schedule was the product of an arm’s length negotiation with DIMA.
Economies of Scale. The Board considered whether there are economies of scale with respect to the management of the Fund and whether the Fund benefits from any economies of scale. In this regard, the Board observed that while the Fund’s current investment management fee schedule does not include breakpoints, the Fund’s fee schedule represents an appropriate sharing between the Fund and DIMA of such economies of scale as may exist in the management of the Fund at current asset levels.
Other Benefits to DIMA and NTI and Their Affiliates. The Board also considered the character and amount of other incidental or “fall-out” benefits received by DIMA and NTI and their affiliates, including any fees received by DIMA for administrative services provided to the Fund, any fees received by an affiliate of DIMA for transfer agency services provided to the Fund and any fees received by an affiliate of DIMA for distribution services. The Board also considered benefits to DIMA related to brokerage and soft-dollar allocations, including allocating brokerage to pay for research generated by parties other than the executing broker dealers, which pertain primarily to funds investing in equity securities. In addition, the Board
considered the incidental public relations benefits to DIMA related to DWS Funds advertising and cross-selling opportunities among DIMA products and services. The Board considered these benefits in reaching its conclusion that the Fund’s management fees were reasonable.
Compliance. The Board considered the significant attention and resources dedicated by DIMA to its compliance processes in recent years. The Board noted in particular (i) the experience, seniority and time commitment of the individuals serving as DIMA’s and the Fund’s chief compliance officers; (ii) the substantial commitment of resources by DIMA and its affiliates to compliance matters, including the retention of compliance personnel; and (iii) ongoing efforts to enhance the compliance program. The Board also considered the attention and resources dedicated by DIMA to the oversight of the investment sub-advisor’s compliance program and compliance with the applicable fund policies and procedures.
Based on all of the information considered and the conclusions reached, the Board determined that the continuation of the Agreements is in the best interests of the Fund. In making this determination, the Board did not give particular weight to any single factor identified above. The Board considered these factors over the course of numerous meetings, certain of which were in executive session with only the Independent Trustees and counsel present. It is possible that individual Independent Trustees may have weighed these factors differently in reaching their individual decisions to approve the continuation of the Agreements.
| (b) The Financial Highlights are included with the Financial Statements under Item 7(a). |
| |
Item 8. | Changes in and Disagreements with Accountants for Open-End Management Investment Companies. |
| |
| Not applicable |
| |
Item 9. | Proxy Disclosures for Open-End Management Investment Companies. |
| |
| Not applicable |
| |
Item 10. | Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies. |
| |
| Not applicable |
| |
Item 11. | Statement Regarding Basis for Approval of Investment Advisory Contract. |
| |
| Not applicable |
| |
Item 12. | Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies. |
| |
| Not applicable |
| |
Item 13. | Portfolio Managers of Closed-End Management Investment Companies. |
| |
| Not applicable |
| |
Item 14. | Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers. |
| |
| Not applicable |
| |
Item 15. | Submission of Matters to a Vote of Security. |
| |
| There were no material changes to the procedures by which shareholders may recommend nominees to the Fund’s Board. The primary function of the Nominating and Governance Committee is to identify and recommend individuals for membership on the Board and oversee the administration of the Board Governance Guidelines. Shareholders may recommend candidates for Board positions by forwarding their correspondence by U.S. mail or courier service to Keith R. Fox, DWS Funds Board Chair, c/o Thomas R. Hiller, Ropes & Gray LLP, Prudential Tower, 800 Boylston Street, Boston, MA 02199-3600. |
| |
Item 16. | Controls and Procedures. |
| |
| (a) | The Chief Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on the evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report. |
| |
| (b) | There have been no changes in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting. |
| |
| |
Item 17. | Disclosure of Securities Lending Activities for Closed-End Management Investment Companies. |
| |
| Not applicable |
| |
Item 18. | Recovery of Erroneously Awarded Compensation. |
| |
| Not applicable |
| |
Item 19. | Exhibits |
| |
| (a)(1) | Not applicable |
| |
| (a)(2) | Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT. |
| |
| (b) | Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) is furnished and attached hereto as Exhibit 99.906CERT. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Registrant: | DWS Small Cap Index VIP, a series of Deutsche DWS Investments VIT Funds |
| |
| |
By: | /s/Hepsen Uzcan Hepsen Uzcan Principal Executive Officer |
| |
Date: | 8/15/2024 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: | /s/Hepsen Uzcan Hepsen Uzcan Principal Executive Officer |
| |
Date: | 8/15/2024 |
| |
| |
| |
By: | /s/Diane Kenneally Diane Kenneally Principal Financial Officer |
| |
Date: | 8/15/2024 |